NCT00645528

Brief Summary

The purpose of this research is to determine if meeting in a group with other subjects with diabetes can reduce barriers to starting insulin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Apr 2008

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 27, 2008

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
6.7 years until next milestone

Results Posted

Study results publicly available

May 8, 2015

Completed
Last Updated

May 8, 2015

Status Verified

May 1, 2015

Enrollment Period

4 months

First QC Date

March 21, 2008

Results QC Date

December 10, 2014

Last Update Submit

May 6, 2015

Conditions

Keywords

insulinteaching

Outcome Measures

Primary Outcomes (3)

  • Change in "Barriers to Insulin Treatment (BIT)" Score From Before to After the Classes

    The Barriers to Insulin Treatment Questionnaire (BIT) was completed at the start of the first visit and at the end of the second visit. The BIT is a 14 item self-administered questionnaire with 5 subscales, each representing a different psychological barrier to insulin treatment. Scales are scored 1-10, representing the mean answer of the 10-point Likert questions for the relevant scale. The higher the score, the greater the barriers to insulin treatment, with the exception of the 2nd scale ("Expectations regarding positive insulin-related outcomes") where the lower the score, the greater the barriers to insulin treatment. An overall sum score is calculated the same way, after inverting the items of the 2nd scale. The overall sum scale is scored 1-10, representing the mean answers of the 10-point Likert questions. The higher the score, the greater the barriers to insulin treatment. Reported here is the change in BIT score from baseline. This was assessed by paired t-test.

    2 weeks

  • Barriers to Insulin Treatment Total Sum Score Visit 1 (Week 0)

    The Barriers to Insulin Treatment Questionnaire (BIT) was completed at the start of the first visit and at the end of the second visit. The BIT is a 14 item self-administered questionnaire with 5 subscales, each representing a different psychological barrier to insulin treatment. Scales are scored 1-10, representing the mean answer of the 10 point Likert questions for the relevant scale. The higher the score, the greater the barriers to insulin treatment, with the exception of the 2nd scale ("Expectations regarding positive insulin-related outcomes") where the lower the score, the greater the barriers to insulin treatment. An overall sum score can be calculated the same way, after inverting the items of the 2nd scale. The overall sum scale is scored 1-10, representing the mean answers of the 10-point Likert questions. The higher the score, the greater the barriers to insulin treatment. The Total Sum Score and each subscale at Visit 1 is reported here.

    Visit 1 (week 0)

  • Barriers to Insulin Treatment Total Sum Score Visit 2 (Week 2)

    The Barriers to Insulin Treatment Questionnaire (BIT) was completed at the start of the first visit and at the end of the second visit. The BIT is a 14 item self-administered questionnaire with 5 subscales, each representing a different psychological barrier to insulin treatment. Scales are scored 1-10, representing the mean answer of the 10-point Likert questions for the relevant scale. The higher the score, the greater the barriers to insulin treatment, with the exception of the 2nd scale ("Expectations regarding positive insulin-related outcomes") where the lower the score, the greater the barriers to insulin treatment. An overall sum score is calculated the same way, after inverting the items of the 2nd scale. The overall sum scale is scored 1-10, representing the mean answers of the 10-point Likert questions. The higher the score, the greater the barriers to insulin treatment. The Total Sum Score and each subscale at Visit 2 is reported here.

    Visit 2 (week 2)

Secondary Outcomes (3)

  • Percent of Patients Who Begin Insulin

    2 weeks

  • Number of Subjects Experiencing Hypoglycemic Symptoms

    2 weeks

  • Number of Patients Experiencing a Severe Hypoglycemic Event

    2 weeks

Study Arms (1)

Insulin Education Class Participants

EXPERIMENTAL

Participation in an insulin educational class at week 0 and again at week 2

Other: Insulin Education Class

Interventions

Participation in an Insulin Education Class at week 0 and week 2

Insulin Education Class Participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary care patient at McGuire Veterans Affairs Medical Center in Richmond, Virginia
  • Age \> 18 years
  • Inadequately controlled diabetes (HbA1c \> 8.0%) and not on insulin (using most recent HbA1c, within 1 month of the first visit)
  • Primary Care Provider referral to insulin initiation/education group
  • Patient brings home glucose readings to first visit

You may not qualify if:

  • Patient is reluctant to participate in a group visit for any reason
  • Patient unwilling to sign consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, 23249, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Insulin Resistance

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperinsulinism

Limitations and Caveats

This was a pilot study. Limitations include the small sample size and lack of a control group.

Results Point of Contact

Title
Sonja K Fredrickson, MD
Organization
Hunter Holmes McGuire VA Medical Center

Study Officials

  • Sonja K Fredrickson, MD

    Hunter Holmes McGuire VA Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2008

First Posted

March 27, 2008

Study Start

April 1, 2008

Primary Completion

August 1, 2008

Study Completion

September 1, 2008

Last Updated

May 8, 2015

Results First Posted

May 8, 2015

Record last verified: 2015-05

Locations